Insulin-Dependent Diabetes Mellitus Clinical Trial
| NCT number | NCT00006160 |
| Other study ID # | dahmsw (completed) |
| Secondary ID | DK48163 |
| Status | Completed |
| Phase | N/A |
| First received | August 8, 2000 |
| Last updated | February 12, 2010 |
A controlled trial to assess the potential benefit of a home based worker in improving control in African-American children with insulin dependent diabetes.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 6 Years to 17 Years |
| Eligibility |
Inclusion Criteria: - Insulin dependent diabetes mellitus |
Allocation: Randomized, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United States | Case Western Reserve University | Cleveland | Ohio |
| Lead Sponsor | Collaborator |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03112343 -
Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment
|
N/A | |
| Completed |
NCT00024518 -
Interferon-Alpha for Diabetes Mellitus Type 1
|
Phase 2 | |
| Completed |
NCT04043260 -
DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy
|
N/A | |
| Completed |
NCT00057499 -
Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics
|
Phase 1 | |
| Completed |
NCT04074317 -
Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
|
Phase 2 | |
| Enrolling by invitation |
NCT04239586 -
Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
|
Phase 4 |